Home >
News >
EXTENDED DEADLINE FOR ABSTRACTS: JULY 26th, 2020, 1st TRANSLATIONAL RESEARCH CONFERENCE on CHRONIC LYMPHOCYTIC LEUKAEMIA
EXTENDED DEADLINE FOR ABSTRACTS: JULY 26th, 2020, 1st TRANSLATIONAL RESEARCH CONFERENCE on CHRONIC LYMPHOCYTIC LEUKAEMIA
May 12, 2020
1st TRANSLATIONAL RESEARCH CONFERENCE
CHRONIC LYMPHOCYTIC LEUKAEMIA
November 17-19, 2020
Paris, France
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek
Due to to COVID-19 related challenges, the conference had been
postponed until November 2020
and the deadline for abstracts extended
until July 26, 2020.
We look forward to seeing you all again
and in the meantime everyone at ESH wishes you all the best. Take care!
ABOUT THE CONFERENCE:
This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of Chronic Lymphocytic Leukaemia (CLL). New data will be presented and spirited debates on how to best to apply these insights to the future of CLL therapy are expected.
Emphasis will be placed on critical discussion, including in small groups. Further to the plenary sessions, the programme includes informal thematic break-out sessions and mentored poster walks.
This meeting will be of interest to:
- Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
- Junior scientists and clinicians (MD, PhD)
- PhD candidates and clinical residents still in-training
Learning objectives:
- Understand recent advances in elucidating the pathogenesis of CLL
- Describe recent data on therapeutic regimens for CLL
- Understand emerging data on mechanisms of resistance to targeted agents in CLL
- Understand the debate about how best to optimize CLL therapy in the future
